The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults

Laura A Da Costa,1,2,*Paul Arora,2,3,* Bibiana García-Bailo,1,2 Mohamed Karmali,1,2 Ahmed El-Sohemy,1 Alaa Badawi2 1Department of Nutritional Sciences, University of Toronto; 2Office of Biotechnology and Population Health, Public Health Agency of Canada; 3Dalla Lana School of Public H...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Da Costa LA, Arora P, García-Bailo B, Karmali M, El-Sohemy A, Badawi A
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://doaj.org/article/4b874f0f7cef4eb9b7d5d1a2bfee46f7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4b874f0f7cef4eb9b7d5d1a2bfee46f7
record_format dspace
spelling oai:doaj.org-article:4b874f0f7cef4eb9b7d5d1a2bfee46f72021-12-02T01:01:21ZThe association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults1178-7007https://doaj.org/article/4b874f0f7cef4eb9b7d5d1a2bfee46f72012-10-01T00:00:00Zhttp://www.dovepress.com/the-association-between-obesity-cardiometabolic-disease-biomarkers-and-a11181https://doaj.org/toc/1178-7007Laura A Da Costa,1,2,*Paul Arora,2,3,* Bibiana García-Bailo,1,2 Mohamed Karmali,1,2 Ahmed El-Sohemy,1 Alaa Badawi2 1Department of Nutritional Sciences, University of Toronto; 2Office of Biotechnology and Population Health, Public Health Agency of Canada; 3Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada *These authors contributed equally to this article Introduction: Obesity is associated with a state of chronic inflammation, and increased cardiometabolic disease risk. The present study examined the relationship between body mass index (BMI) and cardiometabolic and inflammatory biomarkers among normal weight, overweight, and obese Canadian adults.Methods: Subjects (n = 1805, aged 18 to 79 years) from the Canadian Health Measures Survey (CHMS) were examined for associations between BMI, cardiometabolic markers (apolipoprotein [Apo] A1, ApoB, low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], total cholesterol, total cholesterol/HDL ratio [total:HDL-C ratio], triglycerides, and glycosylated hemoglobin [HbA1c]), inflammatory factors (C-reactive protein [CRP], fibrinogen, and homocysteine), and 25-hydroxyvitamin D [25(OH)D]. Bootstrap weights for variance and sampling weights for point estimates were applied to account for the complex survey design. Linear regression models adjusted for age, sex, physical activity, smoking status, and ethnicity (in addition to season of clinic visit, for vitamin D analyses only) were used to examine the association between cardiometabolic markers, inflammatory factors, and BMI in Canadian adults.Results: All biomarkers were significantly associated with BMI (P ≤ 0.001). ApoA1 (β = −0.31, P < 0.0001), HDL-C (β = −0.61, P < 0.0001), and 25(OH)D (β = −0.25, P < 0.0001) were inversely associated with BMI, while all other biomarkers showed positive linear associations. Distinct patterns of association were noted among normal weight, overweight, and obese groups, excluding CRP which showed a significant positive association with BMI in the overall population (β = 2.80, P < 0.0001) and in the normal weight (β = 3.20, P = 0.02), overweight (β = 3.53, P = 0.002), and obese (β = 2.22, P = 0.0002) groups.Conclusions: There is an apparent profile of cardiometabolic and inflammatory biomarkers that emerges as BMI increases from normal weight to obesity. Understanding these profiles may permit developing an effective approach for early risk prediction for cardiometabolic disease.Keywords: obesity, inflammation, biomarkers, cardiometabolic diseaseDa Costa LAArora PGarcía-Bailo BKarmali MEl-Sohemy ABadawi ADove Medical PressarticleSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol 2012, Iss default, Pp 347-355 (2012)
institution DOAJ
collection DOAJ
language EN
topic Specialties of internal medicine
RC581-951
spellingShingle Specialties of internal medicine
RC581-951
Da Costa LA
Arora P
García-Bailo B
Karmali M
El-Sohemy A
Badawi A
The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults
description Laura A Da Costa,1,2,*Paul Arora,2,3,* Bibiana García-Bailo,1,2 Mohamed Karmali,1,2 Ahmed El-Sohemy,1 Alaa Badawi2 1Department of Nutritional Sciences, University of Toronto; 2Office of Biotechnology and Population Health, Public Health Agency of Canada; 3Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada *These authors contributed equally to this article Introduction: Obesity is associated with a state of chronic inflammation, and increased cardiometabolic disease risk. The present study examined the relationship between body mass index (BMI) and cardiometabolic and inflammatory biomarkers among normal weight, overweight, and obese Canadian adults.Methods: Subjects (n = 1805, aged 18 to 79 years) from the Canadian Health Measures Survey (CHMS) were examined for associations between BMI, cardiometabolic markers (apolipoprotein [Apo] A1, ApoB, low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], total cholesterol, total cholesterol/HDL ratio [total:HDL-C ratio], triglycerides, and glycosylated hemoglobin [HbA1c]), inflammatory factors (C-reactive protein [CRP], fibrinogen, and homocysteine), and 25-hydroxyvitamin D [25(OH)D]. Bootstrap weights for variance and sampling weights for point estimates were applied to account for the complex survey design. Linear regression models adjusted for age, sex, physical activity, smoking status, and ethnicity (in addition to season of clinic visit, for vitamin D analyses only) were used to examine the association between cardiometabolic markers, inflammatory factors, and BMI in Canadian adults.Results: All biomarkers were significantly associated with BMI (P ≤ 0.001). ApoA1 (β = −0.31, P < 0.0001), HDL-C (β = −0.61, P < 0.0001), and 25(OH)D (β = −0.25, P < 0.0001) were inversely associated with BMI, while all other biomarkers showed positive linear associations. Distinct patterns of association were noted among normal weight, overweight, and obese groups, excluding CRP which showed a significant positive association with BMI in the overall population (β = 2.80, P < 0.0001) and in the normal weight (β = 3.20, P = 0.02), overweight (β = 3.53, P = 0.002), and obese (β = 2.22, P = 0.0002) groups.Conclusions: There is an apparent profile of cardiometabolic and inflammatory biomarkers that emerges as BMI increases from normal weight to obesity. Understanding these profiles may permit developing an effective approach for early risk prediction for cardiometabolic disease.Keywords: obesity, inflammation, biomarkers, cardiometabolic disease
format article
author Da Costa LA
Arora P
García-Bailo B
Karmali M
El-Sohemy A
Badawi A
author_facet Da Costa LA
Arora P
García-Bailo B
Karmali M
El-Sohemy A
Badawi A
author_sort Da Costa LA
title The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults
title_short The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults
title_full The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults
title_fullStr The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults
title_full_unstemmed The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults
title_sort association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in canadian adults
publisher Dove Medical Press
publishDate 2012
url https://doaj.org/article/4b874f0f7cef4eb9b7d5d1a2bfee46f7
work_keys_str_mv AT dacostala theassociationbetweenobesitycardiometabolicdiseasebiomarkersandinnateimmunityrelatedinflammationincanadianadults
AT arorap theassociationbetweenobesitycardiometabolicdiseasebiomarkersandinnateimmunityrelatedinflammationincanadianadults
AT garcampiacuteabailob theassociationbetweenobesitycardiometabolicdiseasebiomarkersandinnateimmunityrelatedinflammationincanadianadults
AT karmalim theassociationbetweenobesitycardiometabolicdiseasebiomarkersandinnateimmunityrelatedinflammationincanadianadults
AT elsohemya theassociationbetweenobesitycardiometabolicdiseasebiomarkersandinnateimmunityrelatedinflammationincanadianadults
AT badawia theassociationbetweenobesitycardiometabolicdiseasebiomarkersandinnateimmunityrelatedinflammationincanadianadults
AT dacostala associationbetweenobesitycardiometabolicdiseasebiomarkersandinnateimmunityrelatedinflammationincanadianadults
AT arorap associationbetweenobesitycardiometabolicdiseasebiomarkersandinnateimmunityrelatedinflammationincanadianadults
AT garcampiacuteabailob associationbetweenobesitycardiometabolicdiseasebiomarkersandinnateimmunityrelatedinflammationincanadianadults
AT karmalim associationbetweenobesitycardiometabolicdiseasebiomarkersandinnateimmunityrelatedinflammationincanadianadults
AT elsohemya associationbetweenobesitycardiometabolicdiseasebiomarkersandinnateimmunityrelatedinflammationincanadianadults
AT badawia associationbetweenobesitycardiometabolicdiseasebiomarkersandinnateimmunityrelatedinflammationincanadianadults
_version_ 1718403381445263360